{Reference Type}: Journal Article
{Title}: FBXL19 in Endothelial Cells Protects the Heart from Influenza A Infection by Enhancing Antiviral Immunity and Reducing Cellular Senescence Programs.
{Author}: Xia B;Chen H;Taleb SJ;Xi X;Shaheen N;Baoyinna B;Soni S;Mebratu YA;Yount JS;Zhao J;Zhao Y;
{Journal}: Am J Physiol Heart Circ Physiol
{Volume}: 0
{Issue}: 0
{Year}: 2024 Aug 16
{Factor}: 5.125
{DOI}: 10.1152/ajpheart.00371.2024
{Abstract}: Influenza A virus (IAV) infection while primarily affects the lungs, it is often associated with cardiovascular complications. However, the mechanisms underlying this association are not fully understood. Here, we investigated the potential role of FBXL19, a member of the Skp1-Cullin-F-box family of E3 ubiquitin ligase, in IAV-induced cardiac inflammation. We demonstrated that FBXL19 overexpression in endothelial cells (ECs) reduced viral titers and IAV matrix protein 1 (M1) levels, while increasing antiviral genes expression, including interferon (IFN)-α, β, γ and RANTES in the cardiac tissue of IAV-infected mice. Moreover, EC-specific overexpression of FBXL19 attenuated the IAV infection-reduced interferon regulatory factor 3 (IRF3) level without altering its mRNA level, and suppressed cardiac inflammation. Furthermore, IAV infection triggered cellular senescence programs in the heart as indicated by the upregulation of p16 and p21 mRNA levels, and the downregulation of lamin B1 levels, which were partially reversed by FBXL19 overexpression in ECs. Our findings indicate that EC-specific overexpression of FBXL19 protects against IAV-induced cardiac damage by enhancing interferon-mediated antiviral signaling, reducing cardiac inflammation, and suppressing cellular senescence programs.